United Therapeutics (UTHR) Assets Average (2010 - 2026)

United Therapeutics has disclosed Assets Average across 17 years of filings, most recently posting $7.3 billion for Q1 2026.

• Assets Average for Q1 2026 came in at $7.3 billion, down 3.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.3 billion (down 3.4% YoY), and the FY2025 annual result was $7.6 billion, up 4.91% from the prior year.
• Assets Average came in at $7.3 billion for Q1 2026 at United Therapeutics, down from $7.6 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $7.8 billion in Q2 2025 to a low of $5.3 billion in Q1 2022.
• The 5-year median for Assets Average is $6.9 billion (2023), against an average of $6.7 billion.
• Across the five-year window, Assets Average advanced 21.02% in 2023 and retreated 3.4% in 2026, its largest moves.
• United Therapeutics' Assets Average stood at $5.9 billion in 2022, then advanced by 19.99% to $7.1 billion in 2023, then gained by 2.09% to $7.2 billion in 2024, then gained by 5.14% to $7.6 billion in 2025, then declined by 4.18% to $7.3 billion in 2026.
• The last three Assets Average figures came in at $7.3 billion (Q1 2026), $7.6 billion (Q4 2025), and $7.6 billion (Q3 2025), per Business Quant data.